On-Demand Webcast

Getting The First Batch Right

filling of clinical batch

Learn how to prepare for a make-or-break batch

With funding scarce, today’s parenteral drug developers need to make every dollar count on the path to market. Every batch of CTM needs to hit its quality targets on the first run – because there may not be funding for two.

If you’re getting ready for that critical step, don’t miss this special webcast with our experts in first-time-right clinical manufacturing. They’ll share valuable tips on how to plan a CTM project that helps get your trial started on time.

people sitting at a desk
What you’ll learn

Get expert insights to guide your CTM project

Together, our expert presenters share exactly where drug developers need to focus when they’re planning to produce their CTM supply.

Sign up to tap their experience on:

  • Building smart project timelines for a CTM batch
  • GMP-alignment when developing the manufacturing process
  • What to plan for when it comes to primary packaging, API and materials
  • How to identify the right CDMO partner for your project

Meet our expert presenters

Garath Duffy, one of the presenters of the webcast
Garath Duffy,
Head of Supply Chain & Project Management

Garath Duffy joined Vetter in 2009 in the manufacturing site in Ravensburg focussing on compounding.

In 2011 he joined the Process Implementation team to guide Tech Transfer activities for PhIII and Process Qualification for a number of customers in a range of delivery systems.

From 2013 until 2020, Garath worked as a project manager heading up multidisciplinary teams for those same Tech Transfer projects. In 2020 he took over the role as head of Supply Chain and Project Management in our new facility in Rankweil, Austria.

Garath is a Biochemist having studied at Queens University, Belfast and the Open University.


Mark Rauckhorst, one of the presenters of the webscast
Mark Rauckhorst,
Director, Supply Chain & Project Management

Mark Rauckhorst joined Vetter Development Services USA in 2013 as a Project Manager, focusing on early phase clinical projects at Vetter’s first U.S. site, in Chicago.

Prior to joining Vetter Mark was a Project Manager at Regis Technologies where he managed custom synthesis manufacturing projects consisting of process research development, non-cGMP manufacturing, and cGMP production of Phase I & II clinical trial materials.

Mark began his professional career as a small molecule, synthetic organic chemist at Pharmacia Upjohn and Pfizer.

Mark received his Master’s degree in Organic Chemistry from The Ohio State University and his MBA from The University of Rhode Island.

Oliver Okle, one of the presenters of the webcast
Dr. Oliver Okle, Product & Service Manager

Dr. Okle joined Vetter as a Product Manager in 2021, bringing deep operational and analytical expertise to the early phase aseptic filling team at our Ravensburg production hub.
Before that, he honed his product and project management skills at multiple different manufacturing, industrial, and professional services organizations in Germany, including Elma Schmidbauer, NanoCraft Coating, and HJS Consulting.
Dr. Okle holds an MS in microbiology from the University of Konstanz, where he also received his doctorate in human and environmental toxicology.